VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,914,585 | -57.0% | 311,055 | +12.6% | 0.00% | -50.0% |
Q2 2023 | $6,774,033 | -4.1% | 276,153 | -9.0% | 0.00% | 0.0% |
Q1 2023 | $7,063,352 | -9.1% | 303,539 | -1.1% | 0.00% | -33.3% |
Q4 2022 | $7,768,000 | -30.2% | 306,925 | -46.8% | 0.00% | -25.0% |
Q3 2022 | $11,132,000 | +38.4% | 577,377 | +82.8% | 0.00% | +33.3% |
Q2 2022 | $8,045,000 | +1652.7% | 315,898 | +1667.2% | 0.00% | – |
Q1 2022 | $459,000 | -23.0% | 17,876 | +25.6% | 0.00% | – |
Q4 2021 | $596,000 | +2.6% | 14,232 | +6.6% | 0.00% | – |
Q3 2021 | $581,000 | -9.4% | 13,352 | -1.5% | 0.00% | – |
Q2 2021 | $641,000 | -7.0% | 13,552 | +0.8% | 0.00% | – |
Q1 2021 | $689,000 | – | 13,447 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |